Viewing Study NCT01511250


Ignite Creation Date: 2025-12-24 @ 4:46 PM
Ignite Modification Date: 2026-05-15 @ 4:31 PM
Study NCT ID: NCT01511250
Status: COMPLETED
Last Update Posted: 2023-04-12
First Post: 2011-11-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years
Sponsor: Takeda
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Normal healthy adults and children View
None Safety and tolerability View
None Active vaccine View
None Placebo View
None Dengue virus vaccine View
None Immune response View